Abstract
Chemotherapy represents the current mainstay therapeutic approach for most types of cancer. Despite the development of targeted chemotherapeutic strategies, the efficacy of anti-cancer drugs is severely limited by the development of drug resistance. Multidrug resistance (MDR) consists of the simultaneous resistance to various unrelated cytotoxic drugs and is one of the main causes of anticancer treatment failure. One of the principal mechanisms by which cancer cells become MDR involves the overexpression of ATP Binding Cassette (ABC) transporters, such as P-glycoprotein (P-gp), mediating the active efflux of cytotoxic molecules from the cytoplasm. Extracellular vesicles (EVs) are submicron lipid-enclosed vesicles that are released by all cells and which play a fundamental role in intercellular communication in physiological and pathological contexts. EVs have fundamental function at each step of cancer development and progression. They mediate the transmission of MDR through the transfer of vesicle cargo including functional ABC transporters as well as nucleic acids, proteins and lipids. Furthermore, EVs mediate MDR by sequestering anticancer drugs and stimulate cancer cell migration and invasion. EVs also mediate the communication with the tumour microenvironment and the immune system, resulting in increased angiogenesis, metastasis and immune evasion. All these actions contribute directly and indirectly to the development of chemoresistance and treatment failure. In this chapter, we describe the many roles EVs play in the acquisition and spread of chemoresistance in cancer. We also discuss possible uses of EVs as pharmacological targets to overcome EV-mediated drug resistance and the potential that the analysis of tumour-derived EVs offers as chemoresistance biomarkers.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Akao Y, Khoo F, Kumazaki M, Shinohara H, Miki K, Yamada N (2014) Extracellular disposal of tumor-suppressor miRs-145 and -34a via microvesicles and 5-FU resistance of human colon cancer cells. Int J Mol Sci 15(1):1392–1401. https://doi.org/10.3390/ijms15011392
Asare-Werehene M, Nakka K, Reunov A, Chiu CT, Lee WT, Abedini MR, Wang PW, Shieh DB, Dilworth FJ, Carmona E, Le T, Mes-Masson AM, Burger D, Tsang BK (2020) The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance. Oncogene 39(7):1600–1616. https://doi.org/10.1038/s41388-019-1087-9
Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, Weinhage T, Menck K, Hupfeld T, Koch R, Trümper L, Wulf GG (2011) Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A 108(37):15336–15341. https://doi.org/10.1073/pnas.1102855108
Bart J, Groen HJ, Hendrikse NH, van der Graaf WT, Vaalburg W, de Vries EG (2000) The blood-brain barrier and oncology: new insights into function and modulation. Cancer Treat Rev 26(6):449–462. https://doi.org/10.1053/ctrv.2000.0194
Battke C, Ruiss R, Welsch U, Wimberger P, Lang S, Jochum S, Zeidler R (2011) Tumour exosomes inhibit binding of tumour-reactive antibodies to tumour cells and reduce ADCC. Cancer Immunol Immunother 60(5):639–648. https://doi.org/10.1007/s00262-011-0979-5
Bebawy M, Combes V, Lee E, Jaiswal R, Gong J, Bonhoure A, Grau GE (2009) Membrane microparticles mediate transfer of P-glycoprotein to drug sensitive cancer cells. Leukemia 23(9):1643–1649. https://doi.org/10.1038/leu.2009.76
Benito-Martin A, Di Giannatale A, Ceder S, Peinado H (2015) The new deal: a potential role for secreted vesicles in innate immunity and tumor progression. Front Immunol 6:66. https://doi.org/10.3389/fimmu.2015.00066
Bliss SA, Sinha G, Sandiford OA, Williams LM, Engelberth DJ, Guiro K, Isenalumhe LL, Greco SJ, Ayer S, Bryan M, Kumar R, Ponzio NM, Rameshwar P (2016) Mesenchymal stem cell-derived Exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrow. Cancer Res 76(19):5832–5844. https://doi.org/10.1158/0008-5472.Can-16-1092
Bouvy C, Wannez A, Laloy J, Chatelain C, Dogne JM (2017) Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo. Leuk Res 62:70–76. https://doi.org/10.1016/j.leukres.2017.09.014
Bouvy C, Wannez A, Laloy J, Chatelain C, Dogné JM (2017) Transfer of multidrug resistance among acute myeloid leukemia cells via extracellular vesicles and their microRNA cargo. Leuk Res 62:70–76. https://doi.org/10.1016/j.leukres.2017.09.014
Callaghan R, Luk F, Bebawy M (2014) Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? Drug Metab Dispos 42(4):623–631. https://doi.org/10.1124/dmd.113.056176
Campos A, Salomon C, Bustos R, Díaz J, Martínez S, Silva V, Reyes C, Díaz-Valdivia N, Varas-Godoy M, Lobos-González L, Quest AF (2018) Caveolin-1-containing extracellular vesicles transport adhesion proteins and promote malignancy in breast cancer cell lines. Nanomedicine (Lond) 13(20):2597–2609. https://doi.org/10.2217/nnm-2018-0094
Cao YL, Zhuang T, Xing BH, Li N, Li Q (2017) Exosomal DNMT1 mediates cisplatin resistance in ovarian cancer. Cell Biochem Funct 35(6):296–303. https://doi.org/10.1002/cbf.3276
Chabner BA, Roberts TG Jr (2005) Timeline: chemotherapy and the war on cancer. Nat Rev Cancer 5(1):65–72. https://doi.org/10.1038/nrc1529
Chen Y, Liu L, Li J, Du Y, Wang J, Liu J (2019) Effects of long noncoding RNA (linc-VLDLR) existing in extracellular vesicles on the occurrence and multidrug resistance of esophageal cancer cells. Pathol Res Pract 215(3):470–477. https://doi.org/10.1016/j.prp.2018.12.033
Chen WX, Liu XM, Lv MM, Chen L, Zhao JH, Zhong SL, Ji MH, Hu Q, Luo Z, Wu JZ, Tang JH (2014) Exosomes from drug-resistant breast cancer cells transmit chemoresistance by a horizontal transfer of microRNAs. PLoS One 9(4):e95240. https://doi.org/10.1371/journal.pone.0095240
Chen ZS, Robey RW, Belinsky MG, Shchaveleva I, Ren XQ, Sugimoto Y, Ross DD, Bates SE, Kruh GD (2003) Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport. Cancer Res 63(14):4048–4054
Chen WX, Xu LY, Qian Q, He X, Peng WT, Zhu YL, Cheng L (2018) Analysis of miRNA signature differentially expressed in exosomes from adriamycin-resistant and parental human breast cancer cells. Biosci Rep 38(6). https://doi.org/10.1042/bsr20181090
Cheung CH, Huang CC, Tsai FY, Lee JY, Cheng SM, Chang YC, Huang YC, Chen SH, Chang JY (2013) Survivin - biology and potential as a therapeutic target in oncology. Onco Targets Ther 6:1453–1462. https://doi.org/10.2147/ott.S33374
Chung AS, Lee J, Ferrara N (2010) Targeting the tumour vasculature: insights from physiological angiogenesis. Nat Rev Cancer 10(7):505–514. https://doi.org/10.1038/nrc2868
Ciravolo V, Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, Morelli D, Villa A, Della Mina P, Menard S, Filipazzi P, Rivoltini L, Tagliabue E, Pupa SM (2012) Potential role of HER2-overexpressing exosomes in countering trastuzumab-based therapy. J Cell Physiol 227(2):658–667. https://doi.org/10.1002/jcp.22773
Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, Hruban RH, Wolfgang CL, Goggins MG, Dal Molin M, Wang TL, Roden R, Klein AP, Ptak J, Dobbyn L, Schaefer J, Silliman N, Popoli M, Vogelstein JT, Browne JD, Schoen RE, Brand RE, Tie J, Gibbs P, Wong HL, Mansfield AS, Jen J, Hanash SM, Falconi M, Allen PJ, Zhou S, Bettegowda C, Diaz LA Jr, Tomasetti C, Kinzler KW, Vogelstein B, Lennon AM, Papadopoulos N (2018) Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science (New York, NY) 359(6378):926–930. https://doi.org/10.1126/science.aar3247
Cole SP (2014) Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future. Annu Rev Pharmacol Toxicol 54:95–117. https://doi.org/10.1146/annurev-pharmtox-011613-135959
Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (New York, NY) 258(5088):1650–1654. https://doi.org/10.1126/science.1360704
Corcoran C, Rani S, O’Brien K, O'Neill A, Prencipe M, Sheikh R, Webb G, McDermott R, Watson W, Crown J, O'Driscoll L (2012) Docetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomes. PLoS One 7(12):e50999. https://doi.org/10.1371/journal.pone.0050999
Cross SE, Jin YS, Tondre J, Wong R, Rao J, Gimzewski JK (2008) AFM-based analysis of human metastatic cancer cells. Nanotechnology 19(38):384003. https://doi.org/10.1088/0957-4484/19/38/384003
Datta A, Kim H, McGee L, Johnson AE, Talwar S, Marugan J, Southall N, Hu X, Lal M, Mondal D, Ferrer M, Abdel-Mageed AB (2018) High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: a drug repurposing strategy for advanced cancer. Sci Rep 8(1):8161. https://doi.org/10.1038/s41598-018-26411-7
De Rubis G, Rajeev Krishnan S, Bebawy M (2019) Liquid biopsies in cancer diagnosis, monitoring, and prognosis. Trends Pharmacol Sci 40(3):172–186. https://doi.org/10.1016/j.tips.2019.01.006
de Souza PS, Cruz AL, Viola JP, Maia RC (2015) Microparticles induce multifactorial resistance through oncogenic pathways independently of cancer cell type. Cancer Sci 106(1):60–68. https://doi.org/10.1111/cas.12566
Dean M, Rzhetsky A, Allikmets R (2001) The human ATP-binding cassette (ABC) transporter superfamily. Genome Res 11(7):1156–1166. https://doi.org/10.1101/gr.184901
Deep G, Jain A, Kumar A, Agarwal C, Kim S, Leevy WM, Agarwal R (2020) Exosomes secreted by prostate cancer cells under hypoxia promote matrix metalloproteinases activity at pre-metastatic niches. Mol Carcinog 59(3):323–332. https://doi.org/10.1002/mc.23157
Dillekas H, Rogers MS, Straume O (2019) Are 90% of deaths from cancer caused by metastases? Cancer Med 8(12):5574–5576. https://doi.org/10.1002/cam4.2474
Dolo V, D'Ascenzo S, Violini S, Pompucci L, Festuccia C, Ginestra A, Vittorelli ML, Canevari S, Pavan A (1999) Matrix-degrading proteinases are shed in membrane vesicles by ovarian cancer cells in vivo and in vitro. Clin Exp Metastasis 17(2):131–140. https://doi.org/10.1023/a:1006500406240
Dong Y, Pan Q, Jiang L, Chen Z, Zhang F, Liu Y, Xing H, Shi M, Li J, Li X, Zhu Y, Chen Y, Bruce IC, Jin J, Ma X (2014) Tumor endothelial expression of P-glycoprotein upon microvesicular transfer of TrpC5 derived from adriamycin-resistant breast cancer cells. Biochem Biophys Res Commun 446(1):85–90. https://doi.org/10.1016/j.bbrc.2014.02.076
Dong H, Wang W, Chen R, Zhang Y, Zou K, Ye M, He X, Zhang F, Han J (2018) Exosome-mediated transfer of lncRNA-SNHG14 promotes trastuzumab chemoresistance in breast cancer. Int J Oncol 53(3):1013–1026. https://doi.org/10.3892/ijo.2018.4467
Doyle L, Ross DD (2003) Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22(47):7340–7358. https://doi.org/10.1038/sj.onc.1206938
Doyle LA, Yang W, Abruzzo LV, Krogmann T, Gao Y, Rishi AK, Ross DD (1998) A multidrug resistance transporter from human MCF-7 breast cancer cells. Proc Natl Acad Sci U S A 95(26):15665–15670. https://doi.org/10.1073/pnas.95.26.15665
El-Sayed IY, Daher A, Destouches D, Firlej V, Kostallari E, Maillé P, Huet E, Haidar-Ahmad N, Jenster G, de la Taille A, Abou Merhi R, Terry S, Vacherot F (2017) Extracellular vesicles released by mesenchymal-like prostate carcinoma cells modulate EMT state of recipient epithelial-like carcinoma cells through regulation of AR signaling. Cancer Lett 410:100–111. https://doi.org/10.1016/j.canlet.2017.09.010
Faict S, Oudaert I, D’Auria L, Dehairs J, Maes K, Vlummens P, De Veirman K, De Bruyne E, Fostier K, Vande Broek I, Schots R, Vanderkerken K, Swinnen JV, Menu E (2019) The transfer of Sphingomyelinase contributes to drug resistance in multiple myeloma. Cancers 11(12). https://doi.org/10.3390/cancers11121823
Federici C, Petrucci F, Caimi S, Cesolini A, Logozzi M, Borghi M, D'Ilio S, Lugini L, Violante N, Azzarito T, Majorani C, Brambilla D, Fais S (2014) Exosome release and low pH belong to a framework of resistance of human melanoma cells to cisplatin. PLoS One 9(2):e88193. https://doi.org/10.1371/journal.pone.0088193
Fenn JE, Udelsman R (2011) First use of intravenous chemotherapy cancer treatment: rectifying the record. J Am Coll Surg 212(3):413–417. https://doi.org/10.1016/j.jamcollsurg.2010.10.018
Flens MJ, Zaman GJ, van der Valk P, Izquierdo MA, Schroeijers AB, Scheffer GL, van der Groep P, de Haas M, Meijer CJ, Scheper RJ (1996) Tissue distribution of the multidrug resistance protein. Am J Pathol 148(4):1237–1247
Garcia-Romero N, Esteban-Rubio S, Rackov G, Carrion-Navarro J, Belda-Iniesta C, Ayuso-Sacido A (2018) Extracellular vesicles compartment in liquid biopsies: Clinical application. Mol Asp Med 60:27–37. https://doi.org/10.1016/j.mam.2017.11.009
Gillet JP, Gottesman MM (2010) Mechanisms of multidrug resistance in cancer. Methods in molecular biology (Clifton, NJ) 596:47–76. https://doi.org/10.1007/978-1-60761-416-6_4
Ginestra A, La Placa MD, Saladino F, Cassarà D, Nagase H, Vittorelli ML (1998) The amount and proteolytic content of vesicles shed by human cancer cell lines correlates with their in vitro invasiveness. Anticancer Res 18(5a):3433–3437
Goler-Baron V, Assaraf YG (2011) Structure and function of ABCG2-rich extracellular vesicles mediating multidrug resistance. PLoS One 6(1):e16007. https://doi.org/10.1371/journal.pone.0016007
Goler-Baron V, Assaraf YG (2012) Overcoming multidrug resistance via photodestruction of ABCG2-rich extracellular vesicles sequestering photosensitive chemotherapeutics. PLoS One 7(4):e35487. https://doi.org/10.1371/journal.pone.0035487
Gong J, Jaiswal R, Dalla P, Luk F, Bebawy M (2015) Microparticles in cancer: a review of recent developments and the potential for clinical application. Semin Cell Dev Biol 40:35–40. https://doi.org/10.1016/j.semcdb.2015.03.009
Gong J, Luk F, Jaiswal R, Bebawy M (2014) Microparticles mediate the intercellular regulation of microRNA-503 and Proline-rich tyrosine kinase 2 to Alter the migration and invasion capacity of breast cancer cells. Front Oncol 4:220. https://doi.org/10.3389/fonc.2014.00220
Gong J, Luk F, Jaiswal R, George AM, Grau GE, Bebawy M (2013) Microparticle drug sequestration provides a parallel pathway in the acquisition of cancer drug resistance. Eur J Pharmacol 721(1–3):116–125. https://doi.org/10.1016/j.ejphar.2013.09.044
Gopal SK, Greening DW, Rai A, Chen M, Xu R, Shafiq A, Mathias RA, Zhu HJ, Simpson RJ (2017) Extracellular vesicles: their role in cancer biology and epithelial-mesenchymal transition. Biochem J 474(1):21–45. https://doi.org/10.1042/bcj20160006
Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615–627. https://doi.org/10.1146/annurev.med.53.082901.103929
Gottesman MM, Ling V (2006) The molecular basis of multidrug resistance in cancer: the early years of P-glycoprotein research. FEBS Lett 580(4):998–1009. https://doi.org/10.1016/j.febslet.2005.12.060
Graves LE, Ariztia EV, Navari JR, Matzel HJ, Stack MS, Fishman DA (2004) Proinvasive properties of ovarian cancer ascites-derived membrane vesicles. Cancer Res 64(19):7045–7049. https://doi.org/10.1158/0008-5472.Can-04-1800
Gutmann H, Hruz P, Zimmermann C, Beglinger C, Drewe J (2005) Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochem Pharmacol 70(5):695–699. https://doi.org/10.1016/j.bcp.2005.05.031
He L, Liu GQ (2002) Interaction of multidrug resistance reversal agents with P-glycoprotein ATPase activity on blood-brain barrier. Acta Pharmacol Sin 23(5):423–429
Hinger SA, Cha DJ, Franklin JL, Higginbotham JN, Dou Y, Ping J, Shu L, Prasad N, Levy S, Zhang B, Liu Q, Weaver AM, Coffey RJ, Patton JG (2018) Diverse long RNAs are differentially sorted into extracellular vesicles secreted by colorectal cancer cells. Cell Rep 25(3):715–725.e714. https://doi.org/10.1016/j.celrep.2018.09.054
Holohan C, Van Schaeybroeck S, Longley DB, Johnston PG (2013) Cancer drug resistance: an evolving paradigm. Nat Rev Cancer 13(10):714–726. https://doi.org/10.1038/nrc3599
Howlader N NA, Krapcho M, Miller D, Brest A, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (2020) SEER Cancer Statistics Review, 1975–2017, National Cancer Institute. Bethesda, MD, https://seer.cancer.gov/csr/1975_2017/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020
Hu YB, Yan C, Mu L, Mi YL, Zhao H, Hu H, Li XL, Tao DD, Wu YQ, Gong JP, Qin JC (2019) Exosomal Wnt-induced dedifferentiation of colorectal cancer cells contributes to chemotherapy resistance. Oncogene 38(11):1951–1965. https://doi.org/10.1038/s41388-018-0557-9
Ifergan I, Scheffer GL, Assaraf YG (2005) Novel extracellular vesicles mediate an ABCG2-dependent anticancer drug sequestration and resistance. Cancer Res 65(23):10952–10958. https://doi.org/10.1158/0008-5472.Can-05-2021
Jaiswal R, Gong J, Sambasivam S, Combes V, Mathys JM, Davey R, Grau GE, Bebawy M (2012) Microparticle-associated nucleic acids mediate trait dominance in cancer. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 26(1):420–429. https://doi.org/10.1096/fj.11-186817
Jaiswal R, Johnson MS, Pokharel D, Krishnan SR, Bebawy M (2017) Microparticles shed from multidrug resistant breast cancer cells provide a parallel survival pathway through immune evasion. BMC Cancer 17(1):104. https://doi.org/10.1186/s12885-017-3102-2
Jaiswal R, Luk F, Dalla PV, Grau GE, Bebawy M (2013) Breast cancer-derived microparticles display tissue selectivity in the transfer of resistance proteins to cells. PLoS One 8(4):e61515. https://doi.org/10.1371/journal.pone.0061515
Jaiswal R, Luk F, Gong J, Mathys JM, Grau GE, Bebawy M (2012) Microparticle conferred microRNA profiles--implications in the transfer and dominance of cancer traits. Mol Cancer 11:37. https://doi.org/10.1186/1476-4598-11-37
Janas T, Janas MM, Sapoń K, Janas T (2015) Mechanisms of RNA loading into exosomes. FEBS Lett 589(13):1391–1398. https://doi.org/10.1016/j.febslet.2015.04.036
Jaramillo AC, FAS JC, Jansen G, Peters GJ (2018) How to overcome ATP-binding cassette drug efflux transporter-mediated drug resistance? Cancer Drug Resistance 1:6–29
Juliano RL, Ling V (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455(1):152–162. https://doi.org/10.1016/0005-2736(76)90160-7
Jung JH, Lee MY, Choi DY, Lee JW, You S, Lee KY, Kim J, Kim KP (2015) Phospholipids of tumor extracellular vesicles stratify gefitinib-resistant nonsmall cell lung cancer cells from gefitinib-sensitive cells. Proteomics 15(4):824–835. https://doi.org/10.1002/pmic.201400243
Kathawala RJ, Gupta P, Ashby CR Jr, Chen ZS (2015) The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 18:1–17. https://doi.org/10.1016/j.drup.2014.11.002
Kawabata S, Oka M, Shiozawa K, Tsukamoto K, Nakatomi K, Soda H, Fukuda M, Ikegami Y, Sugahara K, Yamada Y, Kamihira S, Doyle LA, Ross DD, Kohno S (2001) Breast cancer resistance protein directly confers SN-38 resistance of lung cancer cells. Biochem Biophys Res Commun 280(5):1216–1223. https://doi.org/10.1006/bbrc.2001.4267
Kharaziha P, Chioureas D, Rutishauser D, Baltatzis G, Lennartsson L, Fonseca P, Azimi A, Hultenby K, Zubarev R, Ullen A, Yachnin J, Nilsson S, Panaretakis T (2015) Molecular profiling of prostate cancer derived exosomes may reveal a predictive signature for response to docetaxel. Oncotarget 6(25):21740–21754. https://doi.org/10.18632/oncotarget.3226
Kholia S, Jorfi S, Thompson PR, Causey CP, Nicholas AP, Inal JM, Lange S (2015) A novel role for peptidylarginine deiminases in microvesicle release reveals therapeutic potential of PAD inhibition in sensitizing prostate cancer cells to chemotherapy. Journal of extracellular vesicles 4:26192. https://doi.org/10.3402/jev.v4.26192
Koch R, Aung T, Vogel D, Chapuy B, Wenzel D, Becker S, Sinzig U, Venkataramani V, von Mach T, Jacob R, Truemper L, Wulf GG (2016) Nuclear trapping through inhibition of Exosomal export by indomethacin increases cytostatic efficacy of doxorubicin and Pixantrone. Clin Cancer Res 22(2):395–404. https://doi.org/10.1158/1078-0432.Ccr-15-0577
Koga Y, Yasunaga M, Moriya Y, Akasu T, Fujita S, Yamamoto S, Matsumura Y (2011) Exosome can prevent RNase from degrading microRNA in feces. J Gastrointest Oncol 2(4):215–222. https://doi.org/10.3978/j.issn.2078-6891.2011.015
Kong JN, He Q, Wang G, Dasgupta S, Dinkins MB, Zhu G, Kim A, Spassieva S, Bieberich E (2015) Guggulsterone and bexarotene induce secretion of exosome-associated breast cancer resistance protein and reduce doxorubicin resistance in MDA-MB-231 cells. Int J Cancer 137(7):1610–1620. https://doi.org/10.1002/ijc.29542
Kosgodage US, Mould R, Henley AB, Nunn AV, Guy GW, Thomas EL, Inal JM, Bell JD, Lange S (2018) Cannabidiol (CBD) is a novel inhibitor for exosome and microvesicle (EMV) release in cancer. Front Pharmacol 9:889. https://doi.org/10.3389/fphar.2018.00889
Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D, Tkach M, Théry C (2016) Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci U S A 113(8):E968–E977. https://doi.org/10.1073/pnas.1521230113
Kreger BT, Johansen ER, Cerione RA, Antonyak MA (2016) The enrichment of Survivin in Exosomes from breast cancer cells treated with paclitaxel promotes cell survival and Chemoresistance. Cancers 8(12). https://doi.org/10.3390/cancers8120111
Krishnan SR, Jaiswal R, Brown RD, Luk F, Bebawy M (2016) Multiple myeloma and persistence of drug resistance in the age of novel drugs (review). Int J Oncol 49(1):33–50. https://doi.org/10.3892/ijo.2016.3516
Krishnan SR, Luk F, Brown RD, Suen H, Kwan Y, Bebawy M (2016) Isolation of human CD138(+) microparticles from the plasma of patients with multiple myeloma. Neoplasia (New York, NY) 18(1):25–32. https://doi.org/10.1016/j.neo.2015.11.011
Kumar A, Jaitak V (2019) Natural products as multidrug resistance modulators in cancer. Eur J Med Chem 176:268–291. https://doi.org/10.1016/j.ejmech.2019.05.027
Kunjachan S, Rychlik B, Storm G, Kiessling F, Lammers T (2013) Multidrug resistance: physiological principles and nanomedical solutions. Adv Drug Deliv Rev 65(13–14):1852–1865. https://doi.org/10.1016/j.addr.2013.09.018
Lawson C, Kovacs D, Finding E, Ulfelder E, Luis-Fuentes V (2017) Extracellular vesicles: evolutionarily conserved mediators of intercellular communication. Yale J Biol Med 90(3):481–491
Levchenko A, Mehta BM, Niu X, Kang G, Villafania L, Way D, Polycarpe D, Sadelain M, Larson SM (2005) Intercellular transfer of P-glycoprotein mediates acquired multidrug resistance in tumor cells. Proc Natl Acad Sci U S A 102(6):1933–1938. https://doi.org/10.1073/pnas.0401851102
Li M, Lu Y, Xu Y, Wang J, Zhang C, Du Y, Wang L, Li L, Wang B, Shen J, Tang J, Song B (2018) Horizontal transfer of exosomal CXCR4 promotes murine hepatocarcinoma cell migration, invasion and lymphangiogenesis. Gene 676:101–109. https://doi.org/10.1016/j.gene.2018.07.018
Liu X (2019) ABC family transporters. Adv Exp Med Biol 1141:13–100. https://doi.org/10.1007/978-981-13-7647-4_2
Liu YY, Han TY, Giuliano AE, Cabot MC (2001) Ceramide glycosylation potentiates cellular multidrug resistance. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 15(3):719–730. https://doi.org/10.1096/fj.00-0223com
Liu YY, Han TY, Giuliano AE, Hansen N, Cabot MC (2000) Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J Biol Chem 275(10):7138–7143. https://doi.org/10.1074/jbc.275.10.7138
Longley DB, Johnston PG (2005) Molecular mechanisms of drug resistance. J Pathol 205(2):275–292. https://doi.org/10.1002/path.1706
Lu JF, Luk F, Gong J, Jaiswal R, Grau GE, Bebawy M (2013) Microparticles mediate MRP1 intercellular transfer and the re-templating of intrinsic resistance pathways. Pharmacol Res 76:77–83. https://doi.org/10.1016/j.phrs.2013.07.009
Lu JF, Pokharel D, Bebawy M (2017) A novel mechanism governing the transcriptional regulation of ABC transporters in MDR cancer cells. Drug Deliv Transl Res 7(2):276–285. https://doi.org/10.1007/s13346-016-0353-4
Lu JF, Pokharel D, Padula MP, Bebawy M (2016) A novel method to detect translation of membrane proteins following microvesicle intercellular transfer of nucleic acids. J Biochem 160(5):281–289. https://doi.org/10.1093/jb/mvw033
Luo X, Wei J, Yang FL, Pang XX, Shi F, Wei YX, Liao BY, Wang JL (2019) Exosomal lncRNA HNF1A-AS1 affects cisplatin resistance in cervical cancer cells through regulating microRNA-34b/TUFT1 axis. Cancer Cell Int 19:323. https://doi.org/10.1186/s12935-019-1042-4
Lv MM, Zhu XY, Chen WX, Zhong SL, Hu Q, Ma TF, Zhang J, Chen L, Tang JH, Zhao JH (2014) Exosomes mediate drug resistance transfer in MCF-7 breast cancer cells and a probable mechanism is delivery of P-glycoprotein. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 35(11):10773–10779. https://doi.org/10.1007/s13277-014-2377-z
Ma X, Chen Z, Hua D, He D, Wang L, Zhang P, Wang J, Cai Y, Gao C, Zhang X, Zhang F, Wang T, Hong T, Jin L, Qi X, Chen S, Gu X, Yang D, Pan Q, Zhu Y, Chen Y, Chen D, Jiang L, Han X, Zhang Y, Jin J, Yao X (2014) Essential role for TrpC5-containing extracellular vesicles in breast cancer with chemotherapeutic resistance. Proc Natl Acad Sci U S A 111(17):6389–6394. https://doi.org/10.1073/pnas.1400272111
Ma Y, Yuwen D, Chen J, Zheng B, Gao J, Fan M, Xue W, Wang Y, Li W, Shu Y, Xu Q, Shen Y (2019) Exosomal transfer of Cisplatin-induced miR-425-3p confers Cisplatin resistance in NSCLC through activating autophagy. Int J Nanomedicine 14:8121–8132. https://doi.org/10.2147/ijn.S221383
Maacha S, Bhat AA, Jimenez L, Raza A, Haris M, Uddin S, Grivel JC (2019) Extracellular vesicles-mediated intercellular communication: roles in the tumor microenvironment and anti-cancer drug resistance. Mol Cancer 18(1):55. https://doi.org/10.1186/s12943-019-0965-7
Madden EC, Gorman AM, Logue SE, Samali A (2020) Tumour Cell Secretome in Chemoresistance and Tumour Recurrence Trends in Cancer
Margolis L, Sadovsky Y (2019) The biology of extracellular vesicles: the known unknowns. PLoS Biol 17(7):e3000363. https://doi.org/10.1371/journal.pbio.3000363
Marleau AM, Chen CS, Joyce JA, Tullis RH (2012) Exosome removal as a therapeutic adjuvant in cancer. J Transl Med 10:134. https://doi.org/10.1186/1479-5876-10-134
McAndrews KM, Kalluri R (2019) Mechanisms associated with biogenesis of exosomes in cancer. Mol Cancer 18(1):52. https://doi.org/10.1186/s12943-019-0963-9
Melo SA, Luecke LB, Kahlert C, Fernandez AF, Gammon ST, Kaye J, LeBleu VS, Mittendorf EA, Weitz J, Rahbari N, Reissfelder C, Pilarsky C, Fraga MF, Piwnica-Worms D, Kalluri R (2015) Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523(7559):177–182. https://doi.org/10.1038/nature14581
Mercer TR, Mattick JS (2013) Structure and function of long noncoding RNAs in epigenetic regulation. Nat Struct Mol Biol 20(3):300–307. https://doi.org/10.1038/nsmb.2480
Mills J, Capece M, Cocucci E, Tessari A, Palmieri D (2019) Cancer-derived extracellular vesicle-associated MicroRNAs in intercellular communication: one Cell's trash is another Cell's treasure. Int J Mol Sci 20(24). https://doi.org/10.3390/ijms20246109
Mulcahy LA, Pink RC, Carter DR (2014) Routes and mechanisms of extracellular vesicle uptake. Journal of extracellular vesicles 3. https://doi.org/10.3402/jev.v3.24641
Muralidharan-Chari V, Kohan HG, Asimakopoulos AG, Sudha T, Sell S, Kannan K, Boroujerdi M, Davis PJ, Mousa SA (2016) Microvesicle removal of anticancer drugs contributes to drug resistance in human pancreatic cancer cells. Oncotarget 7(31):50365–50379. https://doi.org/10.18632/oncotarget.10395
Nanayakkara AK, Follit CA, Chen G, Williams NS, Vogel PD, Wise JG (2018) Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells. Sci Rep 8(1):967. https://doi.org/10.1038/s41598-018-19325-x
Nikolaou M, Pavlopoulou A, Georgakilas AG, Kyrodimos E (2018) The challenge of drug resistance in cancer treatment: a current overview. Clin Exp Metastasis 35(4):309–318. https://doi.org/10.1007/s10585-018-9903-0
Pasquier J, Galas L, Boulange-Lecomte C, Rioult D, Bultelle F, Magal P, Webb G, Le Foll F (2012) Different modalities of intercellular membrane exchanges mediate cell-to-cell p-glycoprotein transfers in MCF-7 breast cancer cells. J Biol Chem 287(10):7374–7387. https://doi.org/10.1074/jbc.M111.312157
Poggio M, Hu T, Pai CC, Chu B, Belair CD, Chang A, Montabana E, Lang UE, Fu Q, Fong L, Blelloch R (2019) Suppression of Exosomal PD-L1 induces systemic anti-tumor immunity and memory. Cell 177(2):414–427.e413. https://doi.org/10.1016/j.cell.2019.02.016
Pokharel D, Padula MP, Lu JF, Jaiswal R, Djordjevic SP, Bebawy M (2016) The role of CD44 and ERM proteins in expression and functionality of P-glycoprotein in breast cancer cells. Molecules (Basel, Switzerland) 21(3):290. https://doi.org/10.3390/molecules21030290
Pokharel D, Padula MP, Lu JF, Tacchi JL, Luk F, Djordjevic SP, Bebawy M (2014) Proteome analysis of multidrug-resistant, breast cancer-derived microparticles. Journal of extracellular vesicles 3. https://doi.org/10.3402/jev.v3.24384
Pokharel D, Roseblade A, Oenarto V, Lu JF, Bebawy M (2017) Proteins regulating the intercellular transfer and function of P-glycoprotein in multidrug-resistant cancer. Ecancermedicalscience 11:768. https://doi.org/10.3332/ecancer.2017.768
Pokharel D, Wijesinghe P, Oenarto V, Lu JF, Sampson DD, Kennedy BF, Wallace VP, Bebawy M (2016) Deciphering cell-to-cell communication in Acquisition of Cancer Traits: extracellular membrane vesicles are regulators of tissue biomechanics. OMICS 20(8):462–469. https://doi.org/10.1089/omi.2016.0072
Qu L, Ding J, Chen C, Wu ZJ, Liu B, Gao Y, Chen W, Liu F, Sun W, Li XF, Wang X, Wang Y, Xu ZY, Gao L, Yang Q, Xu B, Li YM, Fang ZY, Xu ZP, Bao Y, Wu DS, Miao X, Sun HY, Sun YH, Wang HY, Wang LH (2016) Exosome-transmitted lncARSR promotes Sunitinib resistance in renal cancer by acting as a competing endogenous RNA. Cancer Cell 29(5):653–668. https://doi.org/10.1016/j.ccell.2016.03.004
Qu Z, Feng J, Pan H, Jiang Y, Duan Y, Fa Z (2019) Exosomes derived from HCC cells with different invasion characteristics mediated EMT through TGF-β/Smad signaling pathway. Onco Targets Ther 12:6897–6905. https://doi.org/10.2147/ott.S209413
Raimondo S, Pucci M, Alessandro R, Fontana S (2020) Extracellular vesicles and tumor-immune escape: biological functions and clinical perspectives. Int J Mol Sci 21(7). https://doi.org/10.3390/ijms21072286
Rajeev Krishnan S, De Rubis G, Suen H, Joshua D, Lam Kwan Y, Bebawy M (2020) A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma. Blood Cancer J 10(3):37. https://doi.org/10.1038/s41408-020-0304-7
Rak J (2013) Extracellular vesicles - biomarkers and effectors of the cellular interactome in cancer. Front Pharmacol 4:21. https://doi.org/10.3389/fphar.2013.00021
Rana S, Yue S, Stadel D, Zoller M (2012) Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection. Int J Biochem Cell Biol 44(9):1574–1584. https://doi.org/10.1016/j.biocel.2012.06.018
Raposo G, Stoorvogel W (2013) Extracellular vesicles: exosomes, microvesicles, and friends. J Cell Biol 200(4):373–383. https://doi.org/10.1083/jcb.201211138
Reis FR, Vasconcelos FC, Pereira DL, Moellman-Coelho A, Silva KL, Maia RC (2011) Survivin and P-glycoprotein are associated and highly expressed in late phase chronic myeloid leukemia. Oncol Rep 26(2):471–478. https://doi.org/10.3892/or.2011.1296
Roseblade A, Luk F, Ung A, Bebawy M (2015) Targeting microparticle biogenesis: a novel approach to the circumvention of cancer multidrug resistance. Curr Cancer Drug Targets 15(3):205–214. https://doi.org/10.2174/1568009615666150225121508
Ross DD, Yang W, Abruzzo LV, Dalton WS, Schneider E, Lage H, Dietel M, Greenberger L, Cole SP, Doyle LA (1999) Atypical multidrug resistance: breast cancer resistance protein messenger RNA expression in mitoxantrone-selected cell lines. J Natl Cancer Inst 91(5):429–433. https://doi.org/10.1093/jnci/91.5.429
Sambi M, Bagheri L, Szewczuk MR (2019) Current challenges in cancer immunotherapy: multimodal approaches to improve efficacy and patient response rates. J Oncol 2019:4508794. https://doi.org/10.1155/2019/4508794
Samir ELA, Mäger I, Breakefield XO, Wood MJ (2013) Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov 12(5):347–357. https://doi.org/10.1038/nrd3978
Samuel P, Mulcahy LA, Furlong F, McCarthy HO, Brooks SA, Fabbri M, Pink RC, Carter DRF (2018) Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells. Philos Trans R Soc Lond Ser B Biol Sci 373(1737). https://doi.org/10.1098/rstb.2017.0065
Saraswathy M, Gong S (2013) Different strategies to overcome multidrug resistance in cancer. Biotechnol Adv 31(8):1397–1407. https://doi.org/10.1016/j.biotechadv.2013.06.004
Schinkel AH (1999) P-glycoprotein, a gatekeeper in the blood-brain barrier. Adv Drug Deliv Rev 36(2–3):179–194. https://doi.org/10.1016/s0169-409x(98)00085-4
Shan Y, You B, Shi S, Shi W, Zhang Z, Zhang Q, Gu M, Chen J, Bao L, Liu D, You Y (2018) Hypoxia-induced matrix Metalloproteinase-13 expression in Exosomes from nasopharyngeal carcinoma enhances metastases. Cell Death Dis 9(3):382. https://doi.org/10.1038/s41419-018-0425-0
Shao H, Chung J, Lee K, Balaj L, Min C, Carter BS, Hochberg FH, Breakefield XO, Lee H, Weissleder R (2015) Chip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma. Nat Commun 6:6999. https://doi.org/10.1038/ncomms7999
Shapiro AB, Ling V (1994) ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem 269(5):3745–3754
Sharma A (2017) Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity. Nanomedicine (Lond) 12(17):2137–2148. https://doi.org/10.2217/nnm-2017-0184
Skog J, Würdinger T, van Rijn S, Meijer DH, Gainche L, Sena-Esteves M, Curry WT Jr, Carter BS, Krichevsky AM, Breakefield XO (2008) Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 10(12):1470–1476. https://doi.org/10.1038/ncb1800
Skotland T, Sagini K, Sandvig K, Llorente A (2020) An emerging focus on lipids in extracellular vesicles. Adv Drug Deliv Rev. https://doi.org/10.1016/j.addr.2020.03.002
Soldevilla B, Rodriguez M, San Millan C, Garcia V, Fernandez-Perianez R, Gil-Calderon B, Martin P, Garcia-Grande A, Silva J, Bonilla F, Dominguez G (2014) Tumor-derived exosomes are enriched in DeltaNp73, which promotes oncogenic potential in acceptor cells and correlates with patient survival. Hum Mol Genet 23(2):467–478. https://doi.org/10.1093/hmg/ddt437
Spizzo R, Almeida MI, Colombatti A, Calin GA (2012) Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31(43):4577–4587. https://doi.org/10.1038/onc.2011.621
Steinbichler TB, Dudás J, Skvortsov S, Ganswindt U, Riechelmann H, Skvortsova II (2019) Therapy resistance mediated by exosomes. Mol Cancer 18(1):58. https://doi.org/10.1186/s12943-019-0970-x
Swaminathan V, Mythreye K, O'Brien ET, Berchuck A, Blobe GC, Superfine R (2011) Mechanical stiffness grades metastatic potential in patient tumor cells and in cancer cell lines. Cancer Res 71(15):5075–5080. https://doi.org/10.1158/0008-5472.Can-11-0247
Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5(3):219–234. https://doi.org/10.1038/nrd1984
Szollosi D, Rose-Sperling D, Hellmich UA, Stockner T (2018) Comparison of mechanistic transport cycle models of ABC exporters. Biochim Biophys Acta Biomembr 1860(4):818–832. https://doi.org/10.1016/j.bbamem.2017.10.028
Takahashi K, Yan IK, Kogure T, Haga H, Patel T (2014) Extracellular vesicle-mediated transfer of long non-coding RNA ROR modulates chemosensitivity in human hepatocellular cancer. FEBS open bio 4:458–467. https://doi.org/10.1016/j.fob.2014.04.007
Takahashi K, Yan IK, Wood J, Haga H, Patel T (2014) Involvement of extracellular vesicle long noncoding RNA (linc-VLDLR) in tumor cell responses to chemotherapy. Molecular cancer research: MCR 12(10):1377–1387. https://doi.org/10.1158/1541-7786.Mcr-13-0636
Tamaki A, Ierano C, Szakacs G, Robey RW, Bates SE (2011) The controversial role of ABC transporters in clinical oncology. Essays Biochem 50(1):209–232. https://doi.org/10.1042/bse0500209
Taylor J, Bebawy M (2018) Proteins regulating microvesicle biogenesis and multidrug resistance in cancer. Proteomics e1800165. https://doi.org/10.1002/pmic.201800165
Taylor J, Bebawy M (2019) Proteins regulating microvesicle biogenesis and multidrug resistance in cancer. Proteomics 19(1–2):e1800165. https://doi.org/10.1002/pmic.201800165
Taylor J, Jaiswal R, Bebawy M (2017) Calcium-calpain dependent pathways regulate Vesiculation in malignant breast cells. Curr Cancer Drug Targets 17(5):486–494. https://doi.org/10.2174/1568009616666161026165736
Théry C, Ostrowski M, Segura E (2009) Membrane vesicles as conveyors of immune responses. Nat Rev Immunol 9(8):581–593. https://doi.org/10.1038/nri2567
Théry C, Zitvogel L, Amigorena S (2002) Exosomes: composition, biogenesis and function. Nat Rev Immunol 2(8):569–579. https://doi.org/10.1038/nri855
Timaner M, Kotsofruk R, Raviv Z, Magidey K, Shechter D, Kan T, Nevelsky A, Daniel S, de Vries EGE, Zhang T, Kaidar-Person O, Kerbel RS, Shaked Y (2020) Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1. Oncogene 39(1):187–203. https://doi.org/10.1038/s41388-019-0971-7
Torrano V, Royo F, Peinado H, Loizaga-Iriarte A, Unda M, Falcon-Perez JM, Carracedo A (2016) Vesicle-MaNiA: extracellular vesicles in liquid biopsy and cancer. Curr Opin Pharmacol 29:47–53. https://doi.org/10.1016/j.coph.2016.06.003
Torreggiani E, Roncuzzi L, Perut F, Zini N, Baldini N (2016) Multimodal transfer of MDR by exosomes in human osteosarcoma. Int J Oncol 49(1):189–196. https://doi.org/10.3892/ijo.2016.3509
Trajkovic K, Hsu C, Chiantia S, Rajendran L, Wenzel D, Wieland F, Schwille P, Brugger B, Simons M (2008) Ceramide triggers budding of exosome vesicles into multivesicular endosomes. Science (New York, NY) 319(5867):1244–1247. https://doi.org/10.1126/science.1153124
Tsuruo T, Iida H, Nojiri M, Tsukagoshi S, Sakurai Y (1983) Circumvention of vincristine and Adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43(6):2905–2910
Turchinovich A, Drapkina O, Tonevitsky A (2019) Transcriptome of extracellular vesicles: state-of-the-art. Front Immunol 10:202. https://doi.org/10.3389/fimmu.2019.00202
Valadi H, Ekström K, Bossios A, Sjöstrand M, Lee JJ, Lötvall JO (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654–659. https://doi.org/10.1038/ncb1596
van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R (2012) Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol Rev 64(3):676–705. https://doi.org/10.1124/pr.112.005983
van Niel G, D'Angelo G, Raposo G (2018) Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol 19(4):213–228. https://doi.org/10.1038/nrm.2017.125
Vasconcelos MH, Caires HR, Ābols A, Xavier CPR, Linē A (2019) Extracellular vesicles as a novel source of biomarkers in liquid biopsies for monitoring cancer progression and drug resistance. Drug resistance updates: reviews and commentaries in antimicrobial and anticancer chemotherapy 47:100647. https://doi.org/10.1016/j.drup.2019.100647
Vella LJ, Behren A, Coleman B, Greening DW, Hill AF, Cebon J (2017) Intercellular resistance to BRAF inhibition can be mediated by extracellular vesicle-associated PDGFRβ. Neoplasia (New York, NY) 19(11):932–940. https://doi.org/10.1016/j.neo.2017.07.002
Vinay DS, Ryan EP, Pawelec G, Talib WH, Stagg J, Elkord E, Lichtor T, Decker WK, Whelan RL, Kumara H, Signori E, Honoki K, Georgakilas AG, Amin A, Helferich WG, Boosani CS, Guha G, Ciriolo MR, Chen S, Mohammed SI, Azmi AS, Keith WN, Bilsland A, Bhakta D, Halicka D, Fujii H, Aquilano K, Ashraf SS, Nowsheen S, Yang X, Choi BK, Kwon BS (2015) Immune evasion in cancer: mechanistic basis and therapeutic strategies. Semin Cancer Biol 35(Suppl):S185–s198. https://doi.org/10.1016/j.semcancer.2015.03.004
Wang J, Lv B, Su Y, Wang X, Bu J, Yao L (2019) Exosome-mediated transfer of lncRNA HOTTIP promotes Cisplatin resistance in gastric cancer cells by regulating HMGA1/miR-218 Axis. Onco Targets Ther 12:11325–11338. https://doi.org/10.2147/ott.S231846
Wang CC, Tseng CC, Chang HC, Huang KT, Fang WF, Chen YM, Yang CT, Hsiao CC, Lin MC, Ho CK, Yip HK (2017) Circulating microparticles are prognostic biomarkers in advanced non-small cell lung cancer patients. Oncotarget 8(44):75952–75967. https://doi.org/10.18632/oncotarget.18372
Wang X, Xu C, Hua Y, Sun L, Cheng K, Jia Z, Han Y, Dong J, Cui Y, Yang Z (2016) Exosomes play an important role in the process of psoralen reverse multidrug resistance of breast cancer. Journal of experimental & clinical cancer research: CR 35(1):186. https://doi.org/10.1186/s13046-016-0468-y
Wei Y, Lai X, Yu S, Chen S, Ma Y, Zhang Y, Li H, Zhu X, Yao L, Zhang J (2014) Exosomal miR-221/222 enhances tamoxifen resistance in recipient ER-positive breast cancer cells. Breast Cancer Res Treat 147(2):423–431. https://doi.org/10.1007/s10549-014-3037-0
Wolf P (1967) The nature and significance of platelet products in human plasma. Br J Haematol 13(3):269–288
Wu H, Zhou J, Mei S, Wu D, Mu Z, Chen B, Xie Y, Ye Y, Liu J (2017) Circulating exosomal microRNA-96 promotes cell proliferation, migration and drug resistance by targeting LMO7. J Cell Mol Med 21(6):1228–1236. https://doi.org/10.1111/jcmm.13056
Xavier CPR, Caires HR, Barbosa MAG, Bergantim R, Guimarães JE, Vasconcelos MH (2020) The role of extracellular vesicles in the hallmarks of cancer and drug resistance. Cell 9(5). https://doi.org/10.3390/cells9051141
Xu CG, Yang MF, Ren YQ, Wu CH, Wang LQ (2016) Exosomes mediated transfer of lncRNA UCA1 results in increased tamoxifen resistance in breast cancer cells. Eur Rev Med Pharmacol Sci 20(20):4362–4368
Yáñez-Mó M, Siljander PR, Andreu Z, Zavec AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J, Colás E, Cordeiro-da Silva A, Fais S, Falcon-Perez JM, Ghobrial IM, Giebel B, Gimona M, Graner M, Gursel I, Gursel M, Heegaard NH, Hendrix A, Kierulf P, Kokubun K, Kosanovic M, Kralj-Iglic V, Krämer-Albers EM, Laitinen S, Lässer C, Lener T, Ligeti E, Linē A, Lipps G, Llorente A, Lötvall J, Manček-Keber M, Marcilla A, Mittelbrunn M, Nazarenko I, Nolte-'t Hoen EN, Nyman TA, O'Driscoll L, Olivan M, Oliveira C, Pállinger É, Del Portillo HA, Reventós J, Rigau M, Rohde E, Sammar M, Sánchez-Madrid F, Santarém N, Schallmoser K, Ostenfeld MS, Stoorvogel W, Stukelj R, Van der Grein SG, Vasconcelos MH, Wauben MH, De Wever O (2015) Biological properties of extracellular vesicles and their physiological functions. Journal of extracellular vesicles 4:27066. https://doi.org/10.3402/jev.v4.27066
Yang SJ, Wang DD, Li J, Xu HZ, Shen HY, Chen X, Zhou SY, Zhong SL, Zhao JH, Tang JH (2017) Predictive role of GSTP1-containing exosomes in chemotherapy-resistant breast cancer. Gene 623:5–14. https://doi.org/10.1016/j.gene.2017.04.031
Yin J, Zhang J (2011) Multidrug resistance-associated protein 1 (MRP1/ABCC1) polymorphism: from discovery to clinical application. Zhong nan da xue xue bao Yi xue ban = Journal of Central South University Medical sciences 36(10):927–938. https://doi.org/10.3969/j.issn.1672-7347.2011.10.002
Yu DD, Wu Y, Zhang XH, Lv MM, Chen WX, Chen X, Yang SJ, Shen H, Zhong SL, Tang JH, Zhao JH (2016) Exosomes from adriamycin-resistant breast cancer cells transmit drug resistance partly by delivering miR-222. Tumour biology: the journal of the International Society for Oncodevelopmental Biology and Medicine 37(3):3227–3235. https://doi.org/10.1007/s13277-015-4161-0
Zhang Q, Liu RX, Chan KW, Hu J, Zhang J, Wei L, Tan H, Yang X, Liu H (2019) Exosomal transfer of p-STAT3 promotes acquired 5-FU resistance in colorectal cancer cells. J Exp Clin Cancer Res 38(1):320. https://doi.org/10.1186/s13046-019-1314-9
Zhang Z, Yin J, Lu C, Wei Y, Zeng A, You Y (2019) Exosomal transfer of long non-coding RNA SBF2-AS1 enhances chemoresistance to temozolomide in glioblastoma. Journal of experimental & clinical cancer research: CR 38(1):166. https://doi.org/10.1186/s13046-019-1139-6
Zhang FF, Zhu YF, Zhao QN, Yang DT, Dong YP, Jiang L, Xing WX, Li XY, Xing H, Shi M, Chen Y, Bruce IC, Jin J, Ma X (2014) Microvesicles mediate transfer of P-glycoprotein to paclitaxel-sensitive A2780 human ovarian cancer cells, conferring paclitaxel-resistance. Eur J Pharmacol 738:83–90. https://doi.org/10.1016/j.ejphar.2014.05.026
Zhao K, Wang Z, Li X, Liu JL, Tian L, Chen JQ (2019) Exosome-mediated transfer of CLIC1 contributes to the vincristine-resistance in gastric cancer. Mol Cell Biochem 462(1–2):97–105. https://doi.org/10.1007/s11010-019-03613-9
Zheng Z, Chen M, Xing P, Yan X, Xie B (2019) Increased expression of Exosomal AGAP2-AS1 (AGAP2 antisense RNA 1) in breast cancer cells inhibits Trastuzumab-induced cell cytotoxicity. Med Sci Monit 25:2211–2220. https://doi.org/10.12659/msm.915419
Zhong S, Chen X, Wang D, Zhang X, Shen H, Yang S, Lv M, Tang J, Zhao J (2016) MicroRNA expression profiles of drug-resistance breast cancer cells and their exosomes. Oncotarget 7(15):19601–19609. https://doi.org/10.18632/oncotarget.7481
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
De Rubis, G., Bebawy, M. (2021). Extracellular Vesicles in Chemoresistance. In: Mathivanan, S., Fonseka, P., Nedeva, C., Atukorala, I. (eds) New Frontiers: Extracellular Vesicles. Subcellular Biochemistry, vol 97. Springer, Cham. https://doi.org/10.1007/978-3-030-67171-6_9
Download citation
DOI: https://doi.org/10.1007/978-3-030-67171-6_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67170-9
Online ISBN: 978-3-030-67171-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)